Prelude Capital Management, LLC Macrogenics Inc Transaction History

Prelude Capital Management, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$3.31 - $18.51 $47,445 - $265,322	14,334 New	14,334 $60,000
Q4 2023 Feb 14, 2024	BUY	$4.48 - $10.11 $88,704 - $200,178	19,800 Added 190.38%	30,200 $290,000
Q3 2023 Nov 14, 2023	SELL	$4.48 - $6.19 $13,323 - $18,409	-2,974 Reduced 22.24%	10,400 $48,000
Q2 2023 Aug 14, 2023	BUY	$4.62 - $7.54 $61,787 - $100,839	13,374 New	13,374 $71,000
Q4 2020 Feb 16, 2021	SELL	$19.41 - $26.0 $3,882 - $5,200	-200 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$24.69 - $31.6 $2,469 - $3,160	100 Added 100.0%	200 $5,000
Q2 2020 Aug 14, 2020	BUY	$5.2 - $29.12 $520 - $2,912	100 New	100 $3,000
Q1 2020 May 15, 2020	SELL	$4.28 - $12.11 $3,424 - $9,688	-800 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$7.95 - $12.27 $6,360 - $9,816	800 New	800 $9,000
Q3 2019 Nov 14, 2019	SELL	$12.44 - $17.48 $3,383 - $4,754	-272 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$14.51 - $19.71 $3,946 - $5,361	272 New	272 $5,000
Q1 2019 May 15, 2019	SELL	$11.11 - $25.6 $13,587 - $31,308	-1,223 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$11.75 - $21.42 $12,020 - $21,912	1,023 Added 511.5%	1,223 $16,000
Q3 2018 Nov 14, 2018	BUY	$19.26 - $23.46 $3,852 - $4,692	200 New	200 $4,000
Q2 2018 Aug 14, 2018	SELL	$19.78 - $24.67 $5,024 - $6,266	-254 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$18.89 - $32.46 $4,798 - $8,244	254 New	254 $6,000

132

55.4M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $199M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.